DSM, Merck partner to bring Metafolin folate to market

August 6, 2014

DSM has announced its partnership with Merck to distribute and market its L-MTHF Metafolin folate to the dietary supplement and food industries. Metafolin folate is the biologically active form of the naturally-occurring predominant form of folate. It is well absorbed and its bioavailability is not affected by metabolic variations that prevent a large proportion of the population from efficiently converting traditional folic acid into the metabolically active form needed to deliver a wide range of health benefits.

Folates are water-soluble B-vitamins that offer a number of health benefits supported by European Food Safety Authority (EFSA) approved health claims. These include Article 13.1 health claims relating to the role folates play in contributing to normal blood formation, cell division, maternal tissue growth during pregnancy, psychological functions, metabolism of the immune system, amino acid synthesis, and the reduction of tiredness and fatigue.

“We’re delighted to be working with Merck to bring Metafolin to the market,” said Jacob Bauly, Global Marketing Manager, DSM. “Folates are often associated with maternal health, however this vitamin plays a number of vital roles in the body. Metafolin directly enters the metabolic process and could be an effective and safe alternative to folic acid supplementation.”

Press release